Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
Here's Why You Should Retain Fresenius Medical (FMS) Stock Now
09:19am, Tuesday, 19'th Jul 2022
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Fresenius (FMS) Faces Fraud Accusation From US Government
02:40pm, Thursday, 14'th Jul 2022 Zacks Investment Research
The Department of Justice of the U.S. government files a civil complaint against Fresenius (FMS), accusing it of defrauding Medicare and other healthcare programs by billing for unnecessary procedures
Fresenius (FMS) Faces Fraud Accusation From US Government
12:24pm, Thursday, 14'th Jul 2022
The Department of Justice of the U.S. government files a civil complaint against Fresenius (FMS), accusing it of defrauding Medicare and other healthcare programs by billing for unnecessary procedures
9 High-Yield Dividend Aristocrats You Haven't Considered But Definitely Should
01:45pm, Saturday, 09'th Jul 2022 Seeking Alpha
Dividend aristocrats are some of the most time-tested dividend blue-chips in America. But the world is full of top quality and very dependable dividend growth powerhouses.
V.F. Corp: A 4.4% Yielding Dividend Aristocrat Bargain You Don't Want To Miss
11:00am, Sunday, 19'th Jun 2022 Seeking Alpha
If VFC grows as analysts expect by 2025 and returns to historical mid-range fair value, it could deliver 87% total returns or 25% annually. Read more here.
Fresenius: Revisiting The Thesis - Still A Buy
03:44am, Sunday, 19'th Jun 2022
We'll take a look at Fresenius in order to determine if the company still represents a good investment opportunity. Given a recent share price weakness, it's not strange that some investors are wonder
My, Oh, My 11 Incredible High-Yield Dividend Aristocrat Bear Market Buys
04:00pm, Saturday, 18'th Jun 2022 Seeking Alpha
This bear market is the 2nd worst start to the year in US stock market history. Fortunately, the world's best high-yield blue-chips are ready to protect your hard-earned savings.
My, Oh, My 11 Incredible High-Yield Dividend Aristocrat Bear Market Buys
12:00pm, Saturday, 18'th Jun 2022
This bear market is the 2nd worst start to the year in US stock market history. And cracks are beginning to form in credit markets that could potentially send stocks falling even lower in the coming m
Here's Why You Should Retain Fresenius Medical (FMS) Stock Now
11:43am, Tuesday, 14'th Jun 2022 Zacks Investment Research
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
Here's Why You Should Retain Fresenius Medical (FMS) Stock Now
09:18am, Tuesday, 14'th Jun 2022
Fresenius Medical (FMS) continues to gain traction through its broad dialysis product and service portfolio. Intense competition is a woe.
2 Dividend Aristocrat Bargains That Could Potentially Triple In 5 Years
01:00pm, Saturday, 11'th Jun 2022 Seeking Alpha
In the 2022 bear market, aristocrats are outperforming the S&P 500 by 2X and the Nasdaq by 3X, falling just 7% YTD.
Fresenius Medical (FMS) Q1 Earnings & Revenues Top Estimates
02:44pm, Tuesday, 10'th May 2022 Zacks Investment Research
Fresenius Medical's (FMS) first-quarter earnings benefit from strong performance across all the geographic regions and segments.
My, Oh My, 10 Dividend Aristocrat Strong Buys
01:30pm, Tuesday, 10'th May 2022 Seeking Alpha
The markets are in turmoil, crashing at rates that have shocked even market veterans. This creates bargain-hunting opportunities. See 10 aristocrat buys here.
Fresenius Medical (FMS) Q1 Earnings & Revenues Top Estimates
12:03pm, Tuesday, 10'th May 2022
Fresenius Medical's (FMS) first-quarter earnings benefit from strong performance across all the geographic regions and segments.
Fresenius Medical Care AG & Co. (FMS) CEO Rice Powell on Q1 2022 Results - Earnings Call Transcript
12:33pm, Wednesday, 04'th May 2022
Fresenius Medical Care AG & Co. (NYSE:FMS ) Q1 2022 Earnings Conference Call May 4, 2022 9:30 AM ET Company Participants Dominik Heger - Head of IR Rice Powell - CEO Helen Giza - CFO Conference Call P
